AB
PSTX

Amalgamated Bank’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Amalgamated Bank’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,291
Closed -$22K – 2994
2024
Q4 		$22K Hold
2,291
– – ﹤0.01% 2093
2024
Q3 		$7K Hold
2,291
– – ﹤0.01% 2660
2024
Q2 		$7K Hold
2,291
– – ﹤0.01% 2656
2024
Q1 		$7K Sell
2,291
-3,637
-61% -$12.1K ﹤0.01% 2618
2023
Q4 		$20K Sell
5,928
-682
-10% -$1.76K ﹤0.01% 2659
2023
Q3 		$16K Hold
6,610
– – ﹤0.01% 2767
2023
Q2 		$12K Buy
+6,610
New +$16.9K ﹤0.01% 2933
2022
Q2 		– Sell
-3,462
Closed -$16K – 3240
2022
Q1 		$16K Buy
+3,462
New +$15.6K ﹤0.01% 2866

Other funds holding PSTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Amalgamated Bank's PSTX Position: Q1 2025 in Review

Amalgamated Bank sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 2,291 shares — an estimated $22K sold.

Amalgamated Bank first reported a position in PSTX in Q1 2022 and held it in 8 quarters. The position peaked at $22K in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

  • Amalgamated Bank reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Amalgamated Bank sold 2,291 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $22K.
  • Amalgamated Bank first reported a position in Poseida Therapeutics, Inc. Common Stock in Q1 2022 and held it in 8 quarters.
  • Amalgamated Bank's Poseida Therapeutics, Inc. Common Stock position peaked at $22K in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Amalgamated Bank's 13F filing for Q1 2025, filed 25 Apr 2025.